Sultams as Dual Inhibitors of Human Carbonic Anhydrase and Thioredoxin Reductase

Aleksandrs Pustenko1, Raitis Bobrovs1, Venkatesan Saravanan2

  • 1Latvian Institute of Organic Synthesis, Riga, Latvia.

Chemmedchem
|July 19, 2026
PubMed

Insights

New sultam-based compounds show promise as dual inhibitors targeting thioredoxin reductase (TrxR1) and tumor-associated carbonic anhydrases (CA IX/XII) to combat cancer drug resistance.

Area of Science:

  • Medicinal Chemistry
  • Oncology
  • Biochemistry

Background:

  • Cancer drug resistance limits single-target therapies.
  • Dual inhibitors offer a strategy to overcome resistance by targeting multiple pathways.

Purpose of the Study:

  • Design, synthesize, and evaluate novel sultam-based N-acyl derivatives.
  • Assess their potential as dual inhibitors of thioredoxin reductase (TrxR1) and tumor-associated carbonic anhydrases (CA IX and XII).

Main Methods:

  • Synthesis of sultam-based N-acyl derivatives (compounds 8a-k and 9a-k).
  • In vitro screening for thioredoxin reductase (TrxR1) inhibition.
  • Carbonic anhydrase (CA) inhibition assays, including selectivity profiling against off-target isoforms (CA I and CA II).

Main Results:

  • Several compounds exhibited activity against TrxR1, with potency dependent on substituent type and orientation.
  • The derivatives displayed significant selectivity for tumor-associated CA IX and XII over non-tumor isoforms CA I and II.
  • No significant inhibition was observed for off-target isoforms CA I and CA II.

Conclusions:

  • Sultam-based N-acyl derivatives show potential as dual-targeting anticancer agents.
  • These compounds effectively inhibit TrxR1 and selectively target CA IX/XII.
  • Further optimization could lead to novel selective, multi-pathway cancer therapies.

Related Concept Videos

Sulfur Assimilation01:20

Sulfur Assimilation

Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to become...
Preparation and Reactions of Thiols02:33

Preparation and Reactions of Thiols

Thiols are prepared using the hydrosulfide anion as a nucleophile in a nucleophilic substitution reaction with alkyl halides. For instance, bromobutane reacts with sodium hydrosulfide to give butanethiol.
Phase II Reactions: Miscellaneous Conjugation Reactions01:19

Phase II Reactions: Miscellaneous Conjugation Reactions

Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids01:19

Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme activation, sulfur...